The significant cost of systematic reviews and meta-analyses: A call for greater involvement of machine learning to assess the promise of clinical trials
Open Access
- 1 December 2019
- journal article
- review article
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 16, 100443
Abstract
No abstract availableKeywords
Funding Information
- NIH
- Evid Science
This publication has 20 references indexed in Scilit:
- Drugs, Devices, and the FDA: Part 1JACC: Basic To Translational Science, 2016
- Meta-analysis in clinical trials revisitedContemporary Clinical Trials, 2015
- Validating therapeutic targets through human geneticsNature Reviews Drug Discovery, 2013
- Systematic reviews and meta-analysis: Understanding the best evidence in primary healthcareJournal of Family Medicine and Primary Care, 2013
- No evidence or no alternative? Taking responsibility for off‐label prescribingInternal Medicine Journal, 2012
- A Web-based archive of systematic review dataSystematic Reviews, 2012
- Meta-analysis of heterogeneous clinical trials: An empirical exampleContemporary Clinical Trials, 2011
- CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised TrialsPLOS Medicine, 2010
- Animal models and the prediction of efficacy in clinical trials of analgesic drugs: A critical appraisal and call for uniform reporting standardsPain, 2008
- How can we improve the pre-clinical development of drugs for stroke?Trends in Neurosciences, 2007